Skip to main content

Advertisement

Log in

Post-rituximab Burkitt transformation of PTLD: loss of CD20 expression accompanied by a switch in light-chain expression

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig 1

References

  1. Touchard G, Pasdeloup T, Parpeix J, Hauet T, Bauwens M, Dumont G et al (1997) High prevalence and usual persistence of serum monoclonal immunoglobulins evidenced by sensitive methods in renal transplant recipients. Nephrol Dial Transplant 12(6):1199–1203

    Article  CAS  PubMed  Google Scholar 

  2. Au WY, Srivastava G, Wong KY, Chung LP, Ma SK, Wan TS et al (2004) Transformation of diffuse large B-cell lymphoma into pre-B acute lymphoblastic leukemia: clinicopathologic features and clonal relationship. Hum Pathol 35(7):900–903

    Article  CAS  PubMed  Google Scholar 

  3. Au WY, Wong K, So JC, Wan TS, Svrivastava G, Liang R (2009) A unique case of B cell lymphoma relapsing as CD4/CD56 blastic neoplasm. Leuk Lymphoma 50(6):932–936

    Article  CAS  PubMed  Google Scholar 

  4. Timms JM, Bell A, Flavell JR, Murray PG, Rickinson AB, Traverse-Glehen A et al (2003) Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin’s lymphoma. Lancet 361(9353):217–223

    Article  PubMed  Google Scholar 

  5. Oertel SH, Verschuuren E, Reinke P, Zeidler K, Papp-Vary M, Babel N et al (2005) Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD). Am J Transplant 5(12):2901–2906

    Article  CAS  PubMed  Google Scholar 

  6. Chu PG, Chen YY, Molina A, Arber DA, Weiss LM (2002) Recurrent B-cell neoplasms after rituximab therapy: an immunophenotypic and genotypic study. Leuk Lymphoma 43(12):2335–2341

    Article  CAS  PubMed  Google Scholar 

  7. Alvaro-Naranjo T, Jaen-Martinez J, Guma-Padro J, Bosch-Princep R, Salvado-Usach MT (2003) CD20-negative DLBCL transformation after rituximab treatment in follicular lymphoma: a new case report and review of the literature. Ann Hematol 82(9):585–588

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wing Y. Au.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hwang, YY., Wong, K.Y., Leung, R.Y.Y. et al. Post-rituximab Burkitt transformation of PTLD: loss of CD20 expression accompanied by a switch in light-chain expression. Ann Hematol 89, 97–99 (2010). https://doi.org/10.1007/s00277-009-0769-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-009-0769-8

Keywords

Navigation